Should Heritable Gene Editing Be Used on Humans?
By Marcy Darnovsky & George Church,
Wall Street Journal
| 04. 10. 2016
"YES" by George Church; "NO" by Marcy Darnovsky
The development of technology that allows human genes to be edited has stirred tremendous excitement about the potential for treating debilitating and life-threatening diseases. The technology could lead to drugs that would treat cancers and other diseases that currently are incurable.
But another facet of this breakthrough has many scientists and others worried: the possibility that the genetic makeup of sperm and eggs could be edited so that diseases that can be inherited won’t be passed on to children yet to be born. One concern is that gene editing that affects future generations, not just an individual, is too risky given our still incomplete understanding of the human genome and how changes might affect it. Another is that the ability to edit heritable traits could result in so-called designer babies, with parents choosing traits such as intelligence or physical characteristics.
Others say we can meet those challenges, and the potential benefits are too great to pass up.
George Church, professor of genetics at Harvard Medical School, favors a careful exploration of the potential of heritable gene editing. Marcy Darnovsky, executive...
Related Articles
By Ian Sample, The Guardian | 07.04.2024
Biological models of human embryos that can develop heartbeats, spinal cords and other distinctive features will be governed by a code of practice in Britain to ensure that researchers work on them responsibly.
Made from stem cells, they mimic, to...
By Kevin Davies, Genetic Engineering & Biotechnology News | 06.27.2024
Physician-scientist Matthew Porteus, MD, PhD, has been a mainstay in the genome editing field for more than two decades. He trained at Stanford University Medical School before completing his residency and hematology/oncology fellowship at Boston Children’s Hospital/Dana Farber Cancer Institute...
By Peter Aldhous, Scientific American | 07.02.2024
In June a notice posted on the website of the journal Nature set a new scientific record. It withdrew what is now the most highly cited research paper ever to be retracted.
The study, published in 2002 by Catherine Verfaillie...
By Robert F. Service, Science | 07.04.2024
Image by Ed Uthman from Flickr
Last year, the U.S. Food and Drug Administration (FDA) approved two gene therapy procedures that can treat and, in some cases essentially cure sickle cell disease, a genetic blood disorder that causes pain and...